Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Winter Games
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

FDA agrees to review Moderna's mRNA flu vaccine

Digest more
Top News
Overview
Scientific American · 8d
FDA won’t consider a new mRNA vaccine for flu despite the technology’s life-saving promise
The U.S. Food and Drug Administration is refusing to consider a new mRNA flu vaccine made by Moderna, the company revealed in a statement on Tuesday.

Continue reading

 · 9h
Moderna’s mRNA Flu Vaccine Back Under FDA Review
 · 1d
FDA reverses course, will review Moderna's mRNA flu vaccine
 · 1d
FDA reverses course, will review Moderna’s mRNA flu vaccine candidate
The Food and Drug Administration (FDA) has backtracked its initial decision last week of refusing to review Moderna’s mRNA flu vaccine candidate after holding a high-priority meeting with the company.

Continue reading

 · 1d
In reversal, US agrees to review new Moderna flu shot
 · 1d
Moderna got a win from the FDA, but political headwinds remain a concern for vaccine makers
BioSpace
3d

Moderna’s mRNA Tech Could Boost Flu Shot Efficacy. Americans Will Have To Wait

After the FDA’s decision to reject a review of Moderna’s mRNA-1010 flu shot, executives explain what Americans will miss out on as other nations embrace the technology.
Yahoo
5mon

How RFK Jr.’s misguided science on mRNA vaccines is shaping policy − a vaccine expert examines the false claims

Add Yahoo as a preferred source to see more of our stories on Google. RFK Jr. canceled $500 million of funding for research on mRNA vaccine technology. Anadolu/Getty Images At a Sept. 4, 2025, hearing before the Senate Finance Committee, Health and Human ...
  • Privacy
  • Terms